Multinomial network meta-analysis using response rates: relapsed/refractory multiple myeloma treatment rankings differ depending on the choice of outcome

BACKGROUND: Due to the fast growing relapsed/refractory multiple myeloma (RRMM) treatment landscape, a comparison of all the available treatments was warranted. For clinical practice it is important to consider both immediate effects such as response quality and prolonged benefits such as progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: van Beurden-Tan, Chrissy H. Y., Sonneveld, Pieter, Groot, Carin A. Uyl-de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150316/
https://www.ncbi.nlm.nih.gov/pubmed/35637452
http://dx.doi.org/10.1186/s12885-022-09571-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150316/
https://www.ncbi.nlm.nih.gov/pubmed/35637452
http://dx.doi.org/10.1186/s12885-022-09571-8

Ejemplares similares